 |
WHAT WILL BE MISSED Genzyme CEO Henri A. Termeer noted Kennedy’s support of innovation. |
Businesses uneasy without Kennedy
Health, tech firms relied on senator
The death of Senator Edward M. Kennedy is raising concerns about the future of programs he championed that benefited the state’s major employers, particularly in the fields of health care, higher education, and technology. (Full article: 1077 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
